165_21012021_S9
human gut metagenome
ALT
20.0
AST
18.0
C-reactive protein
11.803333333333335
D-dimer
843.0
INSDC center name
Malopolska Centre of Biotechnology
LDH (L)
219.0
Submitter Id
165_21012021_S9
adapters
AGATCGGAAGAGCACACGTCTGAACTCCAGTCA, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
alcohol consumption frequency
3-5 times a week
allergy
yes
antibiotic dose
not provided
antibiotic treatment during hospitalization
no
antibiotics before hospital
no
broad-scale environmental context
material anatomical entity
collection date
2021-01-21
death
no
diabetes
yes
diabetes type
type II diabetes
environmental medium
feces
ethnicity
White
ferritin
1273.0
geographic location (country and/or sea)
Poland
geographic location (latitude)
52.24
geographic location (longitude)
21.02
hospital
PUM
host age
85
host body product
stool
host body site
intestine
host body-mass index
27.7
host height
170
host sex
female
host subject id
165
hypertension
yes
icu
no
interleukin-6
8.8
local environmental context
organism substance
location of the tumour
large intestine
medications dose
200mg, 20mg, 40mg, M3 12j, 0,4 ml Neoparin
nationality
Polish
number of ciggaretes per day
not provided
other medical conditions
yes
other medications
yes
project name
Gut Microbiome Dynamics and Predictive Value in Hospitalized COVID-19 Patients: A Comparative Analysis of Shallow and Deep Shotgun Sequencing
sample human DNA contamination
1.3
sample name
165_21012021_S9
sample storage temperature
-20
scientific_name
human gut metagenome
seasonal allergy
no
sequencing method
MiSeq
smoker
no
smoking frequency
never
smoking habit duration
not provided
subject type
patient (case)
tumour
yes